Key Points
• The intriguing “Check Mark Sign” suggests 3rd cranial nerve involvement in GCA.
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Giant cell arteritis (GCA) is the most frequent systemic vasculitis of medium-sized to larger blood vessels, typically affecting individuals over the age of 50 years.
While biopsy still represents the gold standard in diagnosing GCA, high-resolution magnetic resonance imaging (HR MRI) has increasingly shown potential for non-invasive diagnosis of this condition with numerous studies reporting high sensitivity and specificity [1, 2]. This has recently prompted the European League Against Rheumatism to rank HR MRI as a first-line imaging tool with the main advantages being high standardization of data acquisition, reduced probability to miss positive findings in case of skip lesions, and possible detection of intracranial manifestations [3].
Co-involvement of the visual and oculomotor systems may be seen in up to 20% of cases in GCA potentially leading to a number of severe complications such as anterior ischemic optic neuropathy [4]. While HR MRI has already proven valuable in the workup of visual symptoms in GCA, little is known about the usefulness of HR imaging in the setting of oculomotor symptoms like diplopia—which may be due to the fact that direct visualization of cranial nerves has always been highly challenging beyond their cisternal segments.
The current study by Mournet et al [5] is the first to shed light on this delicate issue: In their paper, the authors investigate the presence of intracranial nerve abnormalities in a retrospective cohort of GCA patients with ocular motor involvement using HR MRI. While the overall number of patients assessed is relatively low (14/64 with diplopia, 8/14 with 3rd cranial nerve (CN) impairment), they show an impressive sensitivity in 7/8 patients with positive 3rd CN involvement on post contrast black-blood and high-resolution T2-weighted imaging—the only exception being one patient suffering from transient diplopia. Intriguingly, this 3rd CN involvement is reported to give rise to a specific imaging sign, which the authors refer to as “Check Mark Sign”: A characteristic ✓-shaped enhancement or T2-weighted hyperintensity within the orbital apex that is due to the typical branching of the 3rd CN within the superior orbital fissure. This imaging finding is nicely presented by the authors using instructive examples and a high interrater agreement is achieved.
However, in patients with either 4th or 6th CN impairment, the authors do not observe any nerve involvement on imaging. On the one hand, this is good news because these patients (1/14 with 4th CN and 5/14 with 6th CN impairment) serve as a convincing internal control group underlining a high degree of specificity with regard to the findings affecting the 3rd cranial nerve. On the other hand, it shows that either (a) technical limitations still preclude successful detection of nerve abnormalities or (b) an alternative pathophysiological process is involved that may not be readily depicted.
In a nutshell, the current work by Mournet et al constitutes a valuable contribution to the imaging diagnostics in GCA further extending the radiological prospect to direct cranial nerve involvement. This becomes feasible by high-resolution imaging, especially by the smart use of black-blood imaging. Their findings give rise to a compelling, almost “Aunt Minnie”-type of imaging sign which may also be of interest in other types of orbital pathologies in the future.
Change history
26 May 2021
The funding note was missing: Open Access funding enabled and organized by Projekt DEAL.
References
Bley TA, Uhl M, Carew J et al (2007) Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 28(9):1722–1727
Klink T, Geiger J, Both M et al (2014) Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology. 273(3):844–852
Dejaco C, Ramiro S, Duftner C et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636–643
Vodopivec I, Rizzo JF III (2018) Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford) 57(suppl_2):ii63–ii72
Mournet S, Sené T, Charbonneau F et al (2021) High-resolution MRI demonstrates signal abnormalities of the 3rd cranial nerve in giant cell arteritis patients with 3rd cranial nerve impairment. Eur Radiol. https://doi.org/10.1007/s00330-020-07595-x
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Daniel Schwarz.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required for this study because it is an editorial comment.
Ethical approval
Institutional Review Board approval was not required because this is an editorial comment.
Methodology
• Editorial comment
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1007/s00330-020-07595-x
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schwarz, D. GCA: Better ✓check for third cranial nerve involvement!. Eur Radiol 31, 4470–4471 (2021). https://doi.org/10.1007/s00330-021-07739-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-07739-7